share_log

Amalgamated Bank Reduces Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Amalgamated Bank Reduces Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

合并后的银行减少在阿卡迪亚医疗保健公司(纳斯达克代码:ACHC)的股票头寸
Defense World ·  2022/09/22 05:42

Amalgamated Bank reduced its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) by 3.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 62,054 shares of the company's stock after selling 2,141 shares during the period. Amalgamated Bank owned approximately 0.07% of Acadia Healthcare worth $4,066,000 as of its most recent filing with the Securities & Exchange Commission.

根据最近提交给美国证券交易委员会的文件,合并银行在第一季度减持了3.3%的Acadia Healthcare Company,Inc.(纳斯达克代码:ACHC-GET Rating)。该机构投资者在此期间出售了2,141股后,持有该公司62,054股股票。截至最近提交给美国证券交易委员会的文件,合并银行拥有Acadia Healthcare约0.07%的股份,价值4,066,000美元。

A number of other large investors have also recently made changes to their positions in ACHC. Invesco Ltd. boosted its stake in shares of Acadia Healthcare by 132.5% during the 4th quarter. Invesco Ltd. now owns 1,598,040 shares of the company's stock worth $97,000,000 after purchasing an additional 910,813 shares during the period. Alliancebernstein L.P. boosted its stake in shares of Acadia Healthcare by 26.3% during the 4th quarter. Alliancebernstein L.P. now owns 2,748,073 shares of the company's stock worth $166,808,000 after purchasing an additional 571,384 shares during the period. Millennium Management LLC boosted its stake in shares of Acadia Healthcare by 136.4% during the 4th quarter. Millennium Management LLC now owns 928,206 shares of the company's stock worth $56,342,000 after purchasing an additional 535,593 shares during the period. Alyeska Investment Group L.P. purchased a new position in shares of Acadia Healthcare during the 1st quarter worth about $28,751,000. Finally, Hawk Ridge Capital Management LP boosted its stake in shares of Acadia Healthcare by 675.6% during the 1st quarter. Hawk Ridge Capital Management LP now owns 497,320 shares of the company's stock worth $32,589,000 after purchasing an additional 433,200 shares during the period. 99.79% of the stock is owned by hedge funds and other institutional investors.

其他一些大型投资者最近也改变了他们在ACHC的头寸。景顺在第四季度增持了132.5%的Acadia Healthcare股票。景顺公司在此期间增持了910,813股,目前持有1,598,040股该公司股票,价值97,000,000美元。联合伯恩斯坦公司在第四季度将其在Acadia Healthcare的持股增加了26.3%。在此期间,联合伯恩斯坦公司又购买了571,384股,现在拥有2,748,073股该公司股票,价值166,808,000美元。千禧管理有限责任公司在第四季度增持了阿卡迪亚医疗保健公司的股份136.4%。Millennium Management LLC现在拥有928,206股该公司的股票,价值56,342,000美元,在此期间又购买了555,593股。Alyeska Investment Group L.P.在第一季度购买了Acadia Healthcare的新头寸,价值约28,751,000美元。最后,鹰岭资本管理有限公司在第一季度将其在阿卡迪亚医疗保健公司的股份增加了675.6%。鹰岭资本管理有限公司在此期间额外购买了433,200股后,目前拥有497,320股该公司股票,价值32,589,000美元。99.79%的股票由对冲基金和其他机构投资者持有。

Get
到达
Acadia Healthcare
阿卡迪亚医疗保健
alerts:
警报:

Wall Street Analysts Forecast Growth

华尔街分析师预测经济增长

Several equities research analysts have recently commented on ACHC shares. Jefferies Financial Group boosted their price target on shares of Acadia Healthcare from $85.00 to $95.00 in a report on Thursday, July 28th. Loop Capital started coverage on shares of Acadia Healthcare in a report on Thursday, June 16th. They issued a "hold" rating and a $72.00 price target for the company. SVB Leerink boosted their price target on shares of Acadia Healthcare from $95.00 to $103.00 and gave the company an "outperform" rating in a report on Friday, August 26th. UBS Group boosted their price target on shares of Acadia Healthcare from $82.00 to $90.00 and gave the company a "buy" rating in a report on Thursday, July 28th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Acadia Healthcare from $70.00 to $82.00 in a report on Monday, August 1st. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $83.88.

几位股票研究分析师最近对ACHC的股票发表了评论。杰富瑞金融集团在7月28日星期四的一份报告中将Acadia Healthcare的股票目标价从85.00美元上调至95.00美元。Loop Capital在6月16日星期四的一份报告中开始报道Acadia Healthcare的股票。他们对该公司的评级为持有,目标价为72.00美元。SVB Leerink在8月26日周五的一份报告中将Acadia Healthcare的股票目标价从95美元上调至103.00美元,并给予该公司“跑赢大盘”的评级。瑞银集团在7月28日周四的一份报告中将Acadia Healthcare的股票目标价从82.00美元上调至90.00美元,并给予该公司“买入”评级。最后,德意志银行Aktiengesellschaft在8月1日星期一的一份报告中将Acadia Healthcare的股票目标价从70.00美元上调至82.00美元。两名分析师对该股的评级为持有,三名分析师对该公司股票的评级为买入。根据MarketBeat,该公司目前的平均评级为“中等买入”,平均目标价为83.88美元.

Acadia Healthcare Trading Down 2.6 %

Acadia Healthcare股价下跌2.6%

NASDAQ ACHC opened at $80.03 on Thursday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.52. Acadia Healthcare Company, Inc. has a 52 week low of $50.07 and a 52 week high of $86.75. The firm has a market cap of $7.27 billion, a PE ratio of 26.24, a price-to-earnings-growth ratio of 2.03 and a beta of 1.28. The company has a 50 day moving average price of $81.28 and a 200 day moving average price of $73.30.
纳斯达克ACHC周四开盘报80.03美元。该公司的速动比率为1.17,流动比率为1.17,债务权益比为0.52。Acadia Healthcare Company,Inc.的52周低点为50.07美元,52周高位为86.75美元。该公司市值为72.7亿美元,市盈率为26.24倍,市盈率为2.03倍,贝塔系数为1.28。该公司的50日移动均线价格为81.28美元,200日移动均线价格为73.30美元。

Acadia Healthcare (NASDAQ:ACHC – Get Rating) last issued its quarterly earnings results on Wednesday, July 27th. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.77 by $0.07. Acadia Healthcare had a net margin of 11.32% and a return on equity of 10.34%. The business had revenue of $651.72 million for the quarter, compared to analyst estimates of $650.80 million. During the same quarter in the prior year, the business posted $0.71 EPS. Acadia Healthcare's revenue for the quarter was up 11.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.08 EPS for the current fiscal year.

阿卡迪亚医疗保健(纳斯达克:ACHC-GET评级)上一次发布季度收益报告是在7月27日星期三。该公司公布本季度每股收益(EPS)为0.84美元,高于分析师普遍预期的0.77美元和0.07美元。Acadia Healthcare的净利润率为11.32%,股本回报率为10.34%。该业务本季度营收为6.5172亿美元,而分析师预期为6.508亿美元。在去年同一季度,该业务公布的每股收益为0.71美元。与去年同期相比,Acadia Healthcare本季度的收入增长了11.9%。卖方分析师预计,Acadia Healthcare Company,Inc.本财年每股收益将达到3.08欧元。

Insider Buying and Selling at Acadia Healthcare

Acadia Healthcare的内幕买卖

In other news, Director William M. Petrie sold 6,000 shares of the company's stock in a transaction on Friday, July 29th. The shares were sold at an average price of $83.42, for a total value of $500,520.00. Following the sale, the director now directly owns 31,769 shares of the company's stock, valued at approximately $2,650,169.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director William Grieco sold 5,000 shares of the company's stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $82.54, for a total value of $412,700.00. Following the sale, the director now directly owns 73,811 shares of the company's stock, valued at approximately $6,092,359.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William M. Petrie sold 6,000 shares of the company's stock in a transaction on Friday, July 29th. The shares were sold at an average price of $83.42, for a total transaction of $500,520.00. Following the completion of the sale, the director now directly owns 31,769 shares in the company, valued at $2,650,169.98. The disclosure for this sale can be found here. In the last quarter, insiders have sold 34,094 shares of company stock worth $2,788,568. 1.90% of the stock is owned by corporate insiders.

另一则消息是,董事威廉·M·皮特里在7月29日(星期五)的一次交易中出售了6,000股该公司股票。这些股票的平均价格为83.42美元,总价值为500,520.00美元。交易完成后,董事现在直接持有该公司31,769股股票,价值约2,650,169.98美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可以通过此超链接。另一则消息是,董事威廉·格里科在9月7日星期三的一笔交易中出售了5,000股该公司股票。这些股票的平均价格为82.54美元,总价值为412,700.00美元。交易完成后,董事现在直接持有该公司73,811股股票,价值约6,092,359.94美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可以通过此超链接。此外,董事威廉·M·皮特里在7月29日(星期五)的一次交易中出售了6,000股该公司股票。这些股票以83.42美元的平均价格出售,总成交金额为500,520.00美元。出售完成后,董事现在直接拥有该公司31,769股,价值2,650,169.98美元。关于这次销售的披露可以找到这里。在上个季度,内部人士出售了34,094股公司股票,价值2,788,568美元。1.90%的股份由企业内部人士持有。

Acadia Healthcare Company Profile

阿卡迪亚医疗保健公司简介

(Get Rating)

(获取评级)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.

阿卡迪亚医疗保健公司在美国和波多黎各提供行为保健服务。该公司在各种环境中为患者提供行为保健服务,包括住院精神病院、专门治疗设施、住宅治疗中心和门诊诊所。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on Acadia Healthcare (ACHC)
  • The Worst May be Over for Target, But is the Stock Safe to Buy?
  • Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
  • Two Fun Stocks The Insiders Are Buying
  • Novavax Remains a Risk-On Stock in a Risk-Off Market
  • General Mills: Superior Returns With Less Volatility
  • 免费获取StockNews.com关于Acadia Healthcare(ACHC)的研究报告
  • 对塔吉特来说,最糟糕的时期可能已经过去,但这只股票买起来安全吗?
  • 这些液态天然气股票准备好上行了吗?
  • 内部人士正在买入的两只有趣的股票
  • 诺华在避险市场中仍是一只冒险的股票
  • 通用磨坊:波动性更小、回报更高

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

接受阿卡迪亚医疗保健日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Acadia Healthcare和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发